Biotech · Private company
Cardiol Therapeutics Inc.
Track this companyFree. Adds Cardiol Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Cannabidiol, pharmaceutically produced with < 5 ppm THCPhase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- CardiolRxPhase 3 · Recurrent PericarditisClinicalTrials.gov · fetched Nov 12, 2026
- CardiolRxPhase 2 · Acute MyocarditisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)PHASE3 · RECRUITING · started Apr 7, 2025ClinicalTrials.gov NCT06708299 · fetched Nov 12, 2026
- Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)PHASE2 · COMPLETED · started Jan 9, 2023ClinicalTrials.gov NCT05494788 · fetched Nov 12, 2026
- Impact of CardiolRx on Myocardial Recovery in Patients With Acute MyocarditisPHASE2 · COMPLETED · started Jul 28, 2022ClinicalTrials.gov NCT05180240 · fetched Nov 12, 2026
- Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk FactorsPHASE2_PHASE3 · TERMINATED · started Apr 30, 2021ClinicalTrials.gov NCT04615949 · fetched Nov 12, 2026